Dapagliflozin associated with higher risk of ketoacidosis in T2DM patients

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2022年 / 1900卷 / 1期
关键词：
D O I：
10.1007/s40278-022-12358-9
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：6 / 6
相关论文
共 50 条
  • [1] Dapagliflozin improves cardiovascular risk factors in Emirati patients with T2DM
    Nada, Aml Mohamed
    Younan, Mariam Adel
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2021, 12
  • [2] Dapagliflozin—redefining treatment of T2DM?
    Edward C. Chao
    Nature Reviews Endocrinology, 2011, 7 : 696 - 697
  • [3] Dapagliflozin Is Safe and Well Tolerated in Older Patients with T2DM
    Mansfield, Traci
    Fioretto, Paola
    Ptaszynska, Agata
    Yavin, Yshai
    Apanovitch, Anne Marie
    Johnsson, Eva
    Parikh, Shamik J.
    List, James F.
    DIABETES, 2014, 63 : A71 - A71
  • [4] Safety of Dapagliflozin in Clinical Trials for T2DM
    Ptaszynska, Agata
    Johnsson, Kristina M.
    Apanovitch, Anne Marie
    Sugg, Jennifer E.
    Parikh, Shamik J.
    List, James F.
    DIABETES, 2012, 61 : A258 - A259
  • [5] Dapagliflozin Pilot Study in Insulin-Resistant T2DM Patients
    Wilding, John P. H.
    Norwood, Paul
    T'joen, Caroline
    Bastien, Arnaud
    List, James F.
    Fiedorek, Fred T.
    DIABETES, 2009, 58 : A129 - A129
  • [6] Genital Infections in Asian Patients with T2DM Receiving Dapagliflozin Treatment
    Ji, Linong
    Nishimura, Rimei
    Cho, Young Min
    Sjostrom, David
    Johnsson, Kristina M.
    Johnsson, Eva
    DIABETES, 2015, 64 : A658 - A658
  • [7] T2DM patients with depression have higher levels of hyperglycemia and cognitive decline than T2DM patients
    Thummasorn, Savitree
    Apichai, Sopida
    Chupradit, Supat
    Sirisattayawong, Pornpen
    Chaiwong, Pachpilai
    Sriwichaiin, Sirawit
    Pratchayasakul, Wasana
    Chattipakorn, Nipon
    Chattipakorn, Siriporn C.
    PLOS ONE, 2022, 17 (08):
  • [8] DIABETES Dapagliflozin-redefining treatment of T2DM?
    Chao, Edward C.
    NATURE REVIEWS ENDOCRINOLOGY, 2011, 7 (12) : 696 - 697
  • [9] Risk of cardiovascular disease in patients with T2DM
    Nature Reviews Endocrinology, 2013, 9 (6) : 316 - 316
  • [10] Cardiovascular safety of dapagliflozin in type 2 diabetes mellitus (T2DM) patients with various degrees of cardiovascular risk
    Sonesson, C.
    Frederich, R.
    Johansson, P. A.
    Gause-Nilsson, I.
    Langkilde, A. M.
    List, J. F.
    EUROPEAN HEART JOURNAL, 2014, 35 : 1072 - 1072
12345